The 2015 Oxford ICSB will be held from April 13th - 16th, 2015 at the Oxford Conference Center in Oxford, Mississippi.
You can download the tentative agenda in pdf format now. We will announce via email when the final agenda becomes available.
Below is a list of our confirmed speakers for the upcoming Conference:
International Speakers:David Briggs, Professor, University of Western Sydney De-an Guo, Professor, Shanghai Institute of Materia Medica, CAS Yue-wei Guo, Professor, Shanghai Institute of Materia Medica, CAS Ai-jun Hou, Professor, Fudan University Werner Knoss, Department Head , Federal Institute for Drugs and Medical Devices Ling-yi Kong, Dean, Professor, China Pharmaceutical University Xiao-dong Luo, Kunming Institute of Botany, CASIrmgard Merfort, Professor, Albert Ludwigs University of Freiburg Chau Van Minh, President of VAST, Vietnam Academy of Science and Technology Pulok K. Mukherjee, Director, School of Natural Products Studies, Jadavpur University San San Nw'e, Rector, University of Pharmacy~Yangon Ranjit Puranik, Chief Executive Officer, Shree Dhootapapeshwar Limited Yong Qin, Professor, SiChuan University Olivier Rabin, Science Director, World Anti-Doping Agency Alexander Shikov, Researcher, St. Petersburg Institute of Pharmacy Wei Wang, Professor, Hunan University of Chinese Medicine Jean-Luc Wolfender, Professor, University of Geneva Haruki Yamada, Professor, Tokyo University of Pharmacy & Life Sciences Mian Zhang, China Pharmaceutical University Yi-zhun Zhu, Dean of Pharmacy, Fudan University
National Speakers:Donald Belsito, Professor, Columbia University Medical Center Mark Blumenthal, Founder & Executive Director, American Botanical Council Josephine Briggs, Director, NIH and National Center for Complementary and Integrative Health (NCCIH) Josef Brinckmann, Vice President of Sustainability, Traditional Medicinals Lou Cantilena, Division Director, Pharmacology & Medical Toxicolgy USU Joe Chang, Chief Scientific Officer and Executive Vice President, Product Development, Nu Skin Pieter Cohen, Assistant Professor of Medicine, CHA Somerville Hospital Primary Care Gary Coody, FDA National Health Fraud Coordinator, Food and Drug Administration Reginald Frye, Professor, University of Florida Bill Gurley, Professor, University of Arkansas for Medical Science Steven Gust, NIDA International Program Director, National Institute of Health Patricia Hansen, Deputy Director , Food and Drug Administration Corey Hilmas, Senior Vice President of Scientific & Regulatory Affairs, Natural Products Association Jonathan Jackson, Chief Executive Officer, Qualyst Paul Jacobson, CEO, Thorne Research Shabana Khan, Principal Scientist, University of Mississippi Rick Kingston, President, Regulatory/Scientific Affairs, Safety Call International Sau (Larry) Lee, Acting Associate Director, Research Policy & Implementation, Food and Drug Administration Donna McMillan, Research Follow, Proctoer & Gamble Steven Musser, Deputy Director for Scientific Operations, Food and Drug Administration Victor Navarro, Chairman, Division of Hepatology, Einstein Medcial Center Kimberely Norman, Director, Institute for In Vitro Sciences, Inc. Mary Paine, Associate Professor, Washington State University Latasha Robinson, Labeling, Dietary Supplement Compliance Branch Chief, Food and Drug Administration Diego Rua, Lead Biologist, Food and Drug Administration Brian Schaneberg, Director of Regulatory & Scientific Affairs, Starbucks Coffee Company Cara Welch, Dietary Supplements Regulations Implementation Team Leader Dietary Supplements, Food and Drug Administration